Pancreatic Cancer Research

ResearcherHallym UniversityNo recent work listed

Hyung‐Joo Kwon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5581-9994; OpenAlex author ID A5057375627. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 1 paper

Papers 3

  1. Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells. Co-author DOI 10.3892/ol.2019.11134↗
  2. A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model. Co-author DOI 10.2147/ott.s186606↗
  3. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model. Last author DOI 10.3390/ijms19072004↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Younghee Lee · 3 shared papers, 2018–2020 · strength 0.32
  2. Sangkyu Park · 2 shared papers, 2018–2020 · strength 0.24
  3. Guang Jer Wu · 2 shared papers, 2018 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.